These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 10768569

  • 1. Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.
    Bouchet LG, Bolch WE, Goddu SM, Howell RW, Rao DV.
    J Nucl Med; 2000 Apr; 41(4):682-7. PubMed ID: 10768569
    [Abstract] [Full Text] [Related]

  • 2. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
    Goddu SM, Bishayee A, Bouchet LG, Bolch WE, Rao DV, Howell RW.
    J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
    [Abstract] [Full Text] [Related]

  • 3. Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer.
    Bishayee A, Rao DV, Srivastava SC, Bouchet LG, Bolch WE, Howell RW.
    J Nucl Med; 2000 Dec; 41(12):2043-50. PubMed ID: 11138691
    [Abstract] [Full Text] [Related]

  • 4. S values for radionuclides localized within the skeleton.
    Bouchet LG, Bolch WE, Howell RW, Rao DV.
    J Nucl Med; 2000 Jan; 41(1):189-212. PubMed ID: 10647623
    [Abstract] [Full Text] [Related]

  • 5. Relative efficacy of 32P and 89Sr in palliation in skeletal metastases.
    Nair N.
    J Nucl Med; 1999 Feb; 40(2):256-61. PubMed ID: 10025832
    [Abstract] [Full Text] [Related]

  • 6. Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.
    Pandit-Taskar N, Batraki M, Divgi CR.
    J Nucl Med; 2004 Aug; 45(8):1358-65. PubMed ID: 15299062
    [Abstract] [Full Text] [Related]

  • 7. [Radioprotection and environmental pollution by the use of the radionuclides 89Sr, 186Re, and 153Sm for pain palliation in metastatic bone diseases. Related calculations].
    Sbonias E.
    Hell J Nucl Med; 2005 Aug; 8(2):68-73. PubMed ID: 16142246
    [Abstract] [Full Text] [Related]

  • 8. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.
    Brundage MD, Crook JM, Lukka H.
    Cancer Prev Control; 1998 Apr; 2(2):79-87. PubMed ID: 9765768
    [Abstract] [Full Text] [Related]

  • 9. Teletherapy and radiopharmaceutical therapy of painful bone metastases.
    Silberstein EB.
    Semin Nucl Med; 2005 Apr; 35(2):152-8. PubMed ID: 15765378
    [Abstract] [Full Text] [Related]

  • 10. [Use of radionuclides in therapy].
    Vucina J, Han R.
    Med Pregl; 2001 Apr; 54(5-6):245-50. PubMed ID: 11759220
    [Abstract] [Full Text] [Related]

  • 11. 186Re-etidronate. Efficacy of palliative radionuclide therapy for painful bone metastases.
    Han SH, De Klerk JM, Zonnenberg BA, Tan S, Van Rijk PP.
    Q J Nucl Med; 2001 Mar; 45(1):84-90. PubMed ID: 11456380
    [Abstract] [Full Text] [Related]

  • 12. Internal radiotherapy of painful bone metastases.
    Liepe K, Kotzerke J.
    Methods; 2011 Nov; 55(3):258-70. PubMed ID: 21803158
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K, Kotzerke J.
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [Abstract] [Full Text] [Related]

  • 14. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H, Bernhardt P, Ericsson T, Forssell-Aronsson E.
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [Abstract] [Full Text] [Related]

  • 15. Radiopharmaceuticals for bone lesions. Imaging and therapy in clinical practice.
    Pauwels EK, Stokkel MP.
    Q J Nucl Med; 2001 Mar; 45(1):18-26. PubMed ID: 11456371
    [Abstract] [Full Text] [Related]

  • 16. An assessment of bone-seeking radionuclides for palliation of metastatic bone pain in a vertebral model.
    Sadremomtaz A, Masoumi M.
    Ann Nucl Med; 2019 Apr; 33(4):252-264. PubMed ID: 30659480
    [Abstract] [Full Text] [Related]

  • 17. Comparative studies on the potential use of 177Lu-based radiopharmaceuticals for the palliative therapy of bone metastases.
    Zakaly HMH, Mostafa MYA, Deryabina D, Zhukovsky M.
    Int J Radiat Biol; 2020 Jun; 96(6):779-789. PubMed ID: 32043915
    [Abstract] [Full Text] [Related]

  • 18. The use of radioisotopes for palliation of metastatic bone pain.
    Gkialas I, Iordanidou L, Galanakis I, Giannopoulos S.
    J BUON; 2008 Jun; 13(2):177-83. PubMed ID: 18555462
    [Abstract] [Full Text] [Related]

  • 19. Radiopharmaceuticals in clinical trials.
    Holmes RA.
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
    [Abstract] [Full Text] [Related]

  • 20. [Palliative treatment of bone metastases with bone-seeking radionuclides].
    De Klerk JM, Zonnenberg BA, Huiskes AW, Han SH, Blijham GH, Van Rijk PP.
    Ned Tijdschr Geneeskd; 1998 Nov 28; 142(48):2618-22. PubMed ID: 10028362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.